ANI Pharmaceuticals Inc (ANIP)
61.68
-0.03
(-0.05%)
USD |
NASDAQ |
May 22, 16:00
61.68
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Revenue (Annual): 486.82M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 486.82M |
| December 31, 2022 | 316.38M |
| December 31, 2021 | 216.14M |
| December 31, 2020 | 208.48M |
| December 31, 2019 | 206.55M |
| December 31, 2018 | 201.58M |
| December 31, 2017 | 176.84M |
| December 31, 2016 | 128.62M |
| December 31, 2015 | 76.32M |
| December 31, 2014 | 55.97M |
| December 31, 2013 | 30.08M |
| December 31, 2012 | 2.301M |
| December 31, 2011 | 0.4352M |
| Date | Value |
|---|---|
| December 31, 2010 | 2.474M |
| December 31, 2009 | 1.258M |
| December 31, 2008 | 3.781M |
| December 31, 2007 | 0.4931M |
| December 31, 2006 | 14.44M |
| December 31, 2005 | 0.2584M |
| December 31, 2004 | 0.0779M |
| December 31, 2003 | 0.0655M |
| December 31, 2002 | 2.834M |
| December 31, 2001 | 1.747M |
| December 31, 2000 | 0.2277M |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.1231M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
206.55M
Minimum
2019
486.82M
Maximum
2023
286.87M
Average
216.14M
Median
2021
Revenue (Annual) Benchmarks
| Ligand Pharmaceuticals Inc | 131.31M |
| ADMA Biologics Inc | 258.22M |
| Annovis Bio Inc | -- |
| United Therapeutics Corp | 2.328B |
| Allogene Therapeutics Inc | 0.095M |